The Zhitong Finance App learned that on Wednesday, Canadian biotech company Repare Therapeutics (RPTX.US) surged about 20% before the market. Earlier, the company announced that it had reached an asset purchase agreement with Gilead Sciences (GILD.US) to acquire its experimental anti-cancer treatment RP-3467, with a total transaction value of up to 30 million US dollars.

Zhitongcaijing · 1d ago
The Zhitong Finance App learned that on Wednesday, Canadian biotech company Repare Therapeutics (RPTX.US) surged about 20% before the market. Earlier, the company announced that it had reached an asset purchase agreement with Gilead Sciences (GILD.US) to acquire its experimental anti-cancer treatment RP-3467, with a total transaction value of up to 30 million US dollars.